Compound Detail

CHEMBL3989945

REZAFUNGIN

💊 Approved Drug

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

💊 Approved Drug

CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](OCC[N+](C)(C)C)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL3989945
Name	REZAFUNGIN
Phase	Approved
Structure Type	MOL
InChI Key	LNFCWEXGZIEGJW-TXSVMFMRSA-O
Therapeutic	✓ Yes

Known Names

Biafungin CD-101 CD101 Rezafungin Rezafungin cation Rezafungin ion SP-3025

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

Indications

Molecular Properties

1226.4

MW (Da)

Drug Information

Molecule Type	Small molecule
First Approval	2023
Availability	Prescription
Chirality	Single Enantiomer

Routes of Administration

Parenteral

Flags

Natural Product

USAN Stem	-fungin
USAN Year	2016

Extended Properties

Molecular Formula	C63H85N8O17+
MW	1226.41

Indications

Mycoses Sepsis

Literature References

PubMed	DOI	Target Context	# Activities
34213340	10.1021/acs.jmedchem.1c00790	ADMET	4

Data from ChEMBL 36 via Core Engine